|Trade names||No-Spa, Doverin|
|AHFS/Drugs.com||International Drug Names|
|Oral, intravenous, intramuscular|
|Bioavailability||Highly variable (~65%), peak at 45–60 min|
|Elimination half-life||7–16 hours|
|Excretion||>50% in urine and ~30% in bile|
|Chemical and physical data|
|Molar mass||397.507 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
An article from 2013 described the effects from overdose (in a 19-year-old woman) as including vomiting, seizures and fatal cardiac toxicity.
In 2016, the young Russian chess player Ivan Bukavshin died of a massive overdose (or poisoning) of the drug, which was originally thought to be a stroke. his doses was 17 mg/kg in the blood stream.
In Israel the product is known under the brand name "No-Spa" by the general public which did not receive a permit to be distributed by the health ministry, However due to high demand local medical counterfeiters had managed to smuggle No-Spa tablets during the years.
In 2011 Israeli patent and trade mark office declined the use of the No-SPA.
- "Инструкция по применению препарата Но-шпа® // No-Spa® (tablets) Full Prescribing Information". National Register of Drugs (in Russian). Chinoin Pharmaceutical and Chemical Works. pp. 3–8.
- Padubidri V and Anand E. Title Textbook of Obstetrics. BI Publications Pvt Ltd, 2006 ISBN 9788172252236
- "The DrugBank database: Drotaverine". DrugBank Version 4.1. The Metabolomics Innovation Centre. Retrieved 9 August 2014.
- Drotaverine - Drugs.com Drugs.com international listings for drotaverine Page accessed June 28, 2015
- Drotaverine overdose (case report) Reactions Weekly, Volume 1481 (1), page 17.
- Silence, lack of will, indifference (Russian, Chess-News)
- NO-SPA (also pronounced as No-SHPA) trade mark registration decision 202248, Israeli patent and trade mark office,11 July 2007
- Health Ministry: Fake drug had been smuggled NRG, 11 March 2009
- Health Ministry: Counterfeit NO-SPA pills had been smuggled and are considered a health risk, Globes